**Abstract**

There are no pharmacological treatments for the core symptoms of Autism Spectrum Disorder (ASD). However, evidence suggests an imbalance between excitatory (E) glutamate and inhibitory (I) GABA in ASD; and may explain the early promise of GABA-glutamate modulating drugs such as riluzole. Here we hypothesised that, compared to controls, individuals with ASD would have differences in the E/I response to a riluzole drug challenge.

Adult men with and without ASD received 50mg p.o riluzole or matched placebo in a randomised, double blind, crossover design, 1hr pre-MRI scan. MEGAPRESS proton magnetic resonance spectroscopy was used to measure Glx (glutamate+glutamine) and GABA in the frontal lobe and subcortex and an inhibitory index was calculated as GABA/(GABA+Glx). Whole brain resting-state fMRI data was acquired as an indirect measure of E/I influence on widespread brain networks. A significance threshold of p \< 0.05 was adopted for all analyses.

Subcortical Glx was significantly lower in men with ASD compared to controls at baseline (placebo); p=0.034. Riluzole significantly increased the inhibitory index in the subcortex of both groups; p=0.048. However, in the frontal lobe, riluzole increased the inhibitory index in the ASD group only; p=0.049. These effects were driven by increases in GABA. The extent to which riluzole increased GABA (or E/I 'responsivity') in the prefrontal lobe was negatively correlated with ASD social domain scores; p=0.019. Additionally, differences in frontal lobe connectivity in ASD appeared 'normalized' by riluzole.

We have shown that brain E/I balance in adults with ASD can be shifted; and that this has widespread effects on brain functional connectivity. The glutamate-GABA system may therefore be a tractable treatment target in ASD. Future work will examine E/I 'responsivity' as a means of 'fractionating' the ASD sample into pharmacologically homogeneous sub-groups; and determine if this approach can predict who will be most responsive to glutamate-GABA treatments (e.g. riluzole).
